SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024122
Filing Date
2021-05-05
Accepted
2021-05-05 16:31:05
Documents
74
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20210331.htm   iXBRL 10-Q 2059908
2 EX-31.1 adpt-ex311_70.htm EX-31.1 27593
3 EX-31.2 adpt-ex312_71.htm EX-31.2 28954
4 EX-32.1 adpt-ex321_68.htm EX-32.1 12138
5 EX-32.2 adpt-ex322_69.htm EX-32.2 13517
  Complete submission text file 0001564590-21-024122.txt   8193357

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adpt-20210331.xsd EX-101.SCH 56682
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20210331_cal.xml EX-101.CAL 52695
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20210331_def.xml EX-101.DEF 199689
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20210331_lab.xml EX-101.LAB 431799
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20210331_pre.xml EX-101.PRE 350244
11 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20210331_htm.xml XML 1611826
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 21893877
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences